Measurable residual disease monitoring provides...

Haematologica 2020 / 01

Measurable residual disease monitoring provides insufficient lead-time to prevent morphologic relapse in the majority of patients with core-binding factor acute myeloid leukemia

Puckrin, Robert, Atenafu, Eshetu G., Claudio, Jaime O., Chan, Steven, Gupta, Vikas, Maze, Dawn, McNamara, Caroline, Murphy, Tracy, Shuh, Andre C., Yee, Karen, Sibai, Hassan, Minden, Mark D., Wei, Cuih
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Journal:
Haematologica
DOI:
10.3324/haematol.2019.235721
Date:
January, 2020
File:
PDF, 2.10 MB
2020
Conversion to is in progress
Conversion to is failed